119 related articles for article (PubMed ID: 11325413)
1. The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-induced changes in temperature, activity, and neurotoxicity.
Russell BR; Laverty R
Pharmacol Biochem Behav; 2001 Mar; 68(3):565-74. PubMed ID: 11325413
[TBL] [Abstract][Full Text] [Related]
2. Correlation between 5-HT content and uptake site density following (S)-MDMA and dexfenfluramine-induced depletion, and with neuroprotection by the glycine site-specific NMDA antagonist ACEA 1021.
Russell BR; Laverty R
Ann N Y Acad Sci; 2000 Sep; 914():208-14. PubMed ID: 11085322
[TBL] [Abstract][Full Text] [Related]
3. 2-Deoxy-D-glucose prevents and nicotinamide potentiates 3, 4-methylenedioxymethamphetamine-induced serotonin neurotoxicity.
Hervías I; Lasheras B; Aguirre N
J Neurochem; 2000 Sep; 75(3):982-90. PubMed ID: 10936179
[TBL] [Abstract][Full Text] [Related]
4. Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR.
Colado MI; Granados R; O'Shea E; Esteban B; Green AR
Br J Pharmacol; 1998 Jun; 124(3):479-84. PubMed ID: 9647471
[TBL] [Abstract][Full Text] [Related]
5. Relevance of MDMA ("ecstasy")-induced neurotoxicity to long-lasting psychomotor stimulation in mice.
Itzhak Y; Ali SF; Achat CN; Anderson KL
Psychopharmacology (Berl); 2003 Mar; 166(3):241-8. PubMed ID: 12590354
[TBL] [Abstract][Full Text] [Related]
6. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
7. Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain.
O'Shea E; Esteban B; Camarero J; Green AR; Colado MI
Neuropharmacology; 2001; 40(1):65-74. PubMed ID: 11077072
[TBL] [Abstract][Full Text] [Related]
8. Serotonin reuptake transporter deficiency modulates the acute thermoregulatory and locomotor activity response to 3,4-(±)-methylenedioxymethamphetamine, and attenuates depletions in serotonin levels in SERT-KO rats.
Lizarraga LE; Phan AV; Cholanians AB; Herndon JM; Lau SS; Monks TJ
Toxicol Sci; 2014 Jun; 139(2):421-31. PubMed ID: 24595820
[TBL] [Abstract][Full Text] [Related]
9. MDMA- and p-chlorophenylalanine-induced reduction in 5-HT concentrations: effects on serotonin transporter densities.
Boot BP; Mechan AO; McCann UD; Ricaurte GA
Eur J Pharmacol; 2002 Oct; 453(2-3):239-44. PubMed ID: 12398910
[TBL] [Abstract][Full Text] [Related]
10. Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX.
Farfel GM; Seiden LS
J Pharmacol Exp Ther; 1995 Feb; 272(2):860-7. PubMed ID: 7531765
[TBL] [Abstract][Full Text] [Related]
11. Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse.
Fantegrossi WE; Kiessel CL; De la Garza R; Woods JH
Psychopharmacology (Berl); 2005 Sep; 181(3):529-36. PubMed ID: 15983787
[TBL] [Abstract][Full Text] [Related]
12. The role of dopaminergic systems in the perinatal sensitivity to 3, 4-methylenedioxymethamphetamine-induced neurotoxicity in rats.
Aguirre N; Barrionuevo M; Lasheras B; Del Río J
J Pharmacol Exp Ther; 1998 Sep; 286(3):1159-65. PubMed ID: 9732373
[TBL] [Abstract][Full Text] [Related]
13. Long-lasting behavioral sensitization to psychostimulants following p-chloroamphetamine-induced neurotoxicity in mice.
Itzhak Y; Achat-Mendes CN; Ali SF; Anderson KL
Neuropharmacology; 2004 Jan; 46(1):74-84. PubMed ID: 14654099
[TBL] [Abstract][Full Text] [Related]
14. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
Colado MI; Murray TK; Green AR
Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
[TBL] [Abstract][Full Text] [Related]
15. Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats.
Thompson MR; Li KM; Clemens KJ; Gurtman CG; Hunt GE; Cornish JL; McGregor IS
Neuropsychopharmacology; 2004 Apr; 29(4):694-704. PubMed ID: 14627999
[TBL] [Abstract][Full Text] [Related]
16. The relationship between core body temperature and 3,4-methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity.
Goni-Allo B; O Mathúna B; Segura M; Puerta E; Lasheras B; de la Torre R; Aguirre N
Psychopharmacology (Berl); 2008 Apr; 197(2):263-78. PubMed ID: 18074122
[TBL] [Abstract][Full Text] [Related]
17. Effect of glucoprivation on serotonin neurotoxicity induced by substituted amphetamines.
Yuan J; Cord BJ; McCann UD; Callahan BT; Ricaurte GA
J Pharmacol Exp Ther; 2002 Nov; 303(2):831-9. PubMed ID: 12388670
[TBL] [Abstract][Full Text] [Related]
18. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
McNamara R; Kerans A; O'Neill B; Harkin A
Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
[TBL] [Abstract][Full Text] [Related]
19. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.
Li Q; Wichems C; Heils A; Van De Kar LD; Lesch KP; Murphy DL
J Pharmacol Exp Ther; 1999 Dec; 291(3):999-1007. PubMed ID: 10565817
[TBL] [Abstract][Full Text] [Related]
20. Increased anxiety 3 months after brief exposure to MDMA ("Ecstasy") in rats: association with altered 5-HT transporter and receptor density.
McGregor IS; Clemens KJ; Van der Plasse G; Li KM; Hunt GE; Chen F; Lawrence AJ
Neuropsychopharmacology; 2003 Aug; 28(8):1472-84. PubMed ID: 12700695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
